'Vaccine Manufacturing Has Its Own Share of Challenges': Serum Institute of India CEO Adar Poonawalla in Exclusive Interview

One of the most critical challenges, Poonawalla told Firstpost, is to build a robust infrastructure that provides a seamless management of all operations. Pune-based SII manufactured the Covishield vaccine against Covid under a licensing agreement with British pharmaceutical giant AstraZeneca

Related Keywords

Pune ,Maharashtra ,India ,United Kingdom ,British ,Adar Poonawalla ,University Of Oxford ,Astrazeneca ,Serum Institute Of India ,Serum Institute ,Many Indians ,Thrombocytopenia Syndrome ,Lok Sabha Election ,Upcoming Phase ,Results Date ,